MML Leong, ML Lung - Frontiers in Oncology, 2021 - frontiersin.org
Epstein-Barr virus (EBV) infection is associated with a variety of malignancies including Burkitt's lymphoma (BL), Hodgkin's disease, T cell lymphoma, nasopharyngeal carcinoma …
DA Moraes, TT Sibov, LF Pavon, PQ Alvim… - Stem cell research & …, 2016 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) are multipotent progenitor cells used in several cell therapies. MSCs are characterized by the expression of CD73, CD90 …
KH Tang, YD Dai, M Tong, YP Chan, PS Kwan, L Fu… - Cancer research, 2013 - AACR
Abstract Tumor-initiating cells (TIC), also known as cancer stem cells, are regarded widely as a specific subpopulation of cells needed for cancer initiation and progression. TICs have …
PHY Lo, HL Lung, AKL Cheung, SS Apte, KW Chan… - Cancer research, 2010 - AACR
ADAMTS metalloprotease family member ADAMTS9 maps to 3p14. 2 and shows significant associations with the aerodigestive tract cancers esophageal squamous cell carcinoma …
EWL Law, AKL Cheung, VI Kashuba, TV Pavlova… - Oncogene, 2012 - nature.com
Abstract Fibulin-2 (FBLN2) has been identified as a candidate tumor-suppressor gene in nasopharyngeal carcinoma (NPC). Originally identified through a chromosome 3 NotI …
ML Lung, AKL Cheung, JMY Ko, HL Lung… - Chinese journal of …, 2014 - ncbi.nlm.nih.gov
The interplay between host cell genetics and Epstein-Barr virus (EBV) infection contributes to the development of nasopharyngeal carcinoma (NPC). Understanding the host genetic …
Thy1/CD90 is an important marker of many types of stem cells. It functions as a tumor suppressor in ovarian cancer and in nasopharyngeal carcinoma. In this study, the …
The rapidly growing collection of diverse genome-scale data from multiple tumor types sheds light on various aspects of the underlying tumor biology. With the objective to identify …
T Kessler, F Sahm, J Blaes, M Osswald, P Rübmann… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Loss of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a prerequisite for tumor cell-specific expression of vascular endothelial growth …